Ambys Medicines
Juan Carlos Izpisua Belmonte, Ph.D. is a Professor and Chair in the Gene Expression Laboratories at the Salk Institute for Biological Studies in La Jolla, California. He is an expert in stem cell biology and innovator in regenerative medicine including in blastocyst complementation. His work has been recognized with awards and honors including the 2016 National Institutes of Health Director’s Pioneer Award, the William Clinton Presidential Award, and the Pew Scholar Award, the Gold Medal of the Junta Castilla-La Mancha and the and the Roger Guillemin Endowed Nobel Chair.
Juan Carlos holds MSc. in pharmacology from the University of Valencia, Spain and a PhD in Biochemistry and Pharmacology at the University of Bologna, Italy. He completed postdoctoral fellowships at the European Molecular Biology Laboratories (EMBL), Germany and at the University of California Los Angeles (UCLA) in the United States.
This person is not in the org chart
This person is not in any offices
Ambys Medicines
Ambys Medicines is a biotechnology company focused on discovering and developing regenerative and restorative therapies for people with advanced liver disease. Founded by world-renowned experts in liver disease and regenerative medicine, Ambys is pioneering the application of novel modalities including cell and gene therapy, and gain-of-function drug therapy, to meet the urgent need for treatments that have the potential to restore liver function and prevent the progression to liver failure across multiple liver diseases that are untreatable or poorly treated today.